100 related articles for article (PubMed ID: 27689995)
1. Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.
Scagnolari C; Corano Scheri G; Selvaggi C; Schietroma I; Najafi Fard S; Mastrangelo A; Giustini N; Serafino S; Pinacchio C; Pavone P; Fanello G; Ceccarelli G; Vullo V; d'Ettorre G
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27689995
[TBL] [Abstract][Full Text] [Related]
2. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.
Scheri GC; Fard SN; Schietroma I; Mastrangelo A; Pinacchio C; Giustini N; Serafino S; De Girolamo G; Cavallari EN; Statzu M; Laghi L; Vullo A; Ceccarelli G; Vullo V; d'Ettorre G
Int J Tryptophan Res; 2017; 10():1178646917710668. PubMed ID: 28607543
[TBL] [Abstract][Full Text] [Related]
5. Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial.
d'Ettorre G; Ceccarelli G; Giustini N; Serafino S; Calantone N; De Girolamo G; Bianchi L; Bellelli V; Ascoli-Bartoli T; Marcellini S; Turriziani O; Brenchley JM; Vullo V
PLoS One; 2015; 10(9):e0137200. PubMed ID: 26376436
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.
Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D
AIDS Res Ther; 2010 Jun; 7():15. PubMed ID: 20525234
[TBL] [Abstract][Full Text] [Related]
7. A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients.
Ceccarelli G; Fratino M; Selvaggi C; Giustini N; Serafino S; Schietroma I; Corano Scheri G; Pavone P; Passavanti G; Alunni Fegatelli D; Mezzaroma I; Antonelli G; Vullo V; Scagnolari C; d'Ettorre G
Brain Behav; 2017 Aug; 7(8):e00756. PubMed ID: 28828217
[TBL] [Abstract][Full Text] [Related]
8. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
[TBL] [Abstract][Full Text] [Related]
10. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
[TBL] [Abstract][Full Text] [Related]
12. Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study.
Ho EL; Spudich SS; Lee E; Fuchs D; Sinclair E; Price RW
AIDS Res Ther; 2011 May; 8():17. PubMed ID: 21569420
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Maloney EM; St Claire Morgan O; Widner B; Werner ER; Fuchs D
J Infect Dis; 2000 Jun; 181(6):2037-40. PubMed ID: 10837188
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
Yilmaz A; Fuchs D; Hagberg L; Nillroth U; Ståhle L; Svensson JO; Gisslén M
BMC Infect Dis; 2006 Mar; 6():63. PubMed ID: 16566834
[TBL] [Abstract][Full Text] [Related]
16. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.
Edén A; Price RW; Spudich S; Fuchs D; Hagberg L; Gisslén M
J Infect Dis; 2007 Dec; 196(12):1779-83. PubMed ID: 18190258
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation.
Dale RC; Brilot F; Fagan E; Earl J
Dev Med Child Neurol; 2009 Apr; 51(4):317-23. PubMed ID: 19191826
[TBL] [Abstract][Full Text] [Related]
18. HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.
Vyboh K; Jenabian MA; Mehraj V; Routy JP
J Immunol Res; 2015; 2015():614127. PubMed ID: 25759844
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection.
Boasso A; Vaccari M; Hryniewicz A; Fuchs D; Nacsa J; Cecchinato V; Andersson J; Franchini G; Shearer GM; Chougnet C
J Virol; 2007 Nov; 81(21):11593-603. PubMed ID: 17715231
[TBL] [Abstract][Full Text] [Related]
20. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
